A new line of research in the fight against Alzheimer’s disease and dementia

“Etienne-Emile Baulieu’s research team (Inserm research unit 788 “Steroids, neuroprotection et neuroregeneration”), in collaboration with Michel Goedert (who originally characterised the Tau protein in Alzheimer’s disease in 1998) have just identified an interaction between the dysfunctional Tau protein and another protein, FKBP52. Using tools from biochemistry and molecular biology, the researchers established that there was a specific physical link between these two proteins in the brain. They demonstrated in vitro that the FKBP52 protein suppressed activity of the Tau protein, and hence prevented its role in the assembly of microtubules, known for their role in transporting nutrient and information-bearing molecules into the cell…” More…